Miguel A. Molina

Instituto Oncologico Dr Rosell
Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2021

Camera-LiDAR Multi-Level Sensor Fusion for Target Detection at the Network Edge.

Camera-LiDAR Multi-Level Sensor Fusion for Target Detection at the Network Edge.

Journal: Sensors (Basel, Switzerland)
Published: May 26, 2021

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.

Journal: Nature communications
Published: March 26, 2021

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells.

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells.

Journal: NPJ precision oncology
Published: January 09, 2021

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2019

Characterising acquired resistance to erlotinib in non-small cell lung cancer patients.

Characterising acquired resistance to erlotinib in non-small cell lung cancer patients.

Journal: Expert review of respiratory medicine
Published: August 15, 2019

Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis.

Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: October 01, 2018

A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.

A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.

Journal: Oncology research and treatment
Published: August 22, 2018

Possible application of circulating free tumor DNA in non-small cell lung cancer patients.

Possible application of circulating free tumor DNA in non-small cell lung cancer patients.

Journal: Journal of thoracic disease
Published: November 30, 2017

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 30, 2017

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC).

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC).

Journal: Oncotarget
Published: March 07, 2017

Liquid biopsy in early stage lung cancer.

Liquid biopsy in early stage lung cancer.

Journal: Translational lung cancer research
Published: November 09, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026